Cell Proliferation Assay

KD Katelyn L Donahue
HW Hannah R Watkoske
PK Padma Kadiyala
WD Wenting Du
KB Kristee Brown
MS Michael K Scales
AE Ahmed M Elhossiny
CE Carlos E Espinoza
EO Emily L Lasse Opsahl
BG Brian D Griffith
YW Yukang Wen
LS Lei Sun
AV Ashley Velez-Delgado
NR Nur M Renollet
JM Jacqueline Morales
NN Nicholas M Nedzesky
RB Rachael K Baliira
RM Rosa E Menjivar
PM Paola I Medina-Cabrera
AR Arvind Rao
BA Benjamin Allen
JS Jiaqi Shi
TF Timothy L Frankel
EC Eileen S Carpenter
FB Filip Bednar
ask Ask a question
Favorite

“IL33 WT” and “IL33 KO” cell lines were seeded at 3 × 103 cells per well in DMEM + 10% FBS + 1% PS in four opaque-walled 96-well plates and left to adhere overnight. The following day, cell density was measured on 1 plate (day 0); the remaining plates were aspirated and washed with PBS, and cells were treated with low-serum DMEM or a 1:1 ratio of low-serum DMEM and 9805 “KRASG12D ON” tumor CM. Conditions without tumor CM were given doxycycline as a control. Plates were collected and read every 24 hours for 3 days. Proliferation was measured using CellTiter-Glo Luminescent Cell Viability Assay (#G7570, Promega) following the manufacturer’s instructions. Two wells per condition were averaged for each measurement.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A